Fidelity Investments’s Ambrx Biopharma Inc AMAM Stock Holding History

Fidelity Investments’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,474,258	Closed	-$21M	–	5811
2023 Q4	$21M	Sell	1,474,258 -286,800	-16%	-$3.26M	﹤0.01%	1608
2023 Q3	$20.3M	Sell	1,761,058 -449,560	-20%	-$6.12M	﹤0.01%	1579
2023 Q2	$36.4M	Hold	2,210,618	–	–	﹤0.01%	1389
2023 Q1	$19.7M	Sell	2,210,618 -485,446	-18%	-$2.44M	﹤0.01%	1613
2022 Q4	$6.12M	Sell	2,696,064 -892,403	-25%	-$1.02M	﹤0.01%	2057
2022 Q3	$3.88M	Sell	3,588,467 -269,212	-7%	-$554K	﹤0.01%	2241
2022 Q2	$10.2M	Buy	3,857,679 +32,320	+0.8%	+$123K	﹤0.01%	1956
2022 Q1	$15.8M	Sell	3,825,359 -29,666	-0.8%	-$152K	﹤0.01%	1901
2021 Q4	$34.8M	Sell	3,855,025 -1,200	-0%	-$13.4K	﹤0.01%	1571
2021 Q3	$50.3M	Buy	3,856,225 +89,285	+2%	+$1.61M	﹤0.01%	1407
2021 Q2	$68.7M	Buy	+3,766,940	New	+$64.2M	0.01%	1293

Fidelity Investments's AMAM Position: Q1 2024 in Review

Fidelity Investments sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 1,474,258 shares — an estimated $21M sold.

Fidelity Investments first reported a position in AMAM in Q2 2021 and held it in 11 quarters. The position peaked at $68.7M in Q2 2021. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Fidelity Investments reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Fidelity Investments sold 1,474,258 Ambrx Biopharma Inc shares in Q1 2024, an estimated $21M.
Fidelity Investments first reported a position in Ambrx Biopharma Inc in Q2 2021 and held it in 11 quarters.
Fidelity Investments's Ambrx Biopharma Inc position peaked at $68.7M in Q2 2021.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.